{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T10:53:42Z","timestamp":1695552822527},"reference-count":34,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.5022","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T22:22:52Z","timestamp":1444861372000},"page":"2629-2635","source":"Crossref","is-referenced-by-count":6,"title":["Type 1 Diabetes Mellitus and Isolated Adrenocorticotropin Deficiency Manifested by Parkinsonism: A Case Report and Literature Review"],"prefix":"10.2169","volume":"54","author":[{"given":"Nobumasa","family":"Ohara","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Niigata Medical Center, Japan"},{"name":"Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Niigata Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Niigata Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Ikarashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Niigata Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Sone","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Oki","sequence":"additional","affiliation":[{"name":"Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyuzi","family":"Kamoi","sequence":"additional","affiliation":[{"name":"Center of Diabetes, Endocrinology and Metabolism, Joetsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Niigata Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Niigata Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Andrioli M, Pecori Giraldi F, Cavagnini F. Isolated corticotrophin deficiency. Pituitary 9: 289-295, 2006.","DOI":"10.1007\/s11102-006-0408-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nemoto K, Kawanishi Y, Suzuki H, Mizukami K, Asada T. Isolated adrenocorticotropic hormone deficiency presenting with delirium. Am J Psychiatry 164: 1440, 2007.","DOI":"10.1176\/appi.ajp.2007.07010193"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tatsuzawa Y, Ono Y, Takahashi T, Yoshino A, Nomura S. Case of isolated adrenocorticotropic hormone deficiency mimicking major depressive disorder. Psychiatry Clin Neurosci 65: 302, 2011.","DOI":"10.1111\/j.1440-1819.2011.02207.x"},{"key":"4","unstructured":"4. Committee of the Japan Diabetes Society on type 1 diabetes. Diagnostic criteria for slowly progressive insulin-dependent (type 1) diabetes mellitus (SPDDIM) (2012): Report by the Committee on Slowly Progressive Insulin-dependent (Type 1) Diabetes Mellitus of the Japan Diabetes Society. Tonyobyo (J Japan Diab Soc) 56: 590-597, 2013 (in Japanese, Abstract in English)."},{"key":"5","unstructured":"5. Wieland RG, Wieland JM. Isolated adrenocorticotropic hormone deficiency with antepartum pituitary infarction in a type I diabetic. Obstet Gynecol 65 (3 Suppl): 58S-59S, 1985."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sandler R, Proudfoot GR. Isolated ACTH deficiency contributing to frequent hypoglycemia in type I diabetes. Diabetes Care 8: 302-304, 1985.","DOI":"10.2337\/diacare.8.3.302b"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Giustina A, Candrina R, Cimino A, Romanelli G. Development of isolated ACTH deficiency in a man with type I diabetes mellitus. J Endocrinol Invest 11: 375-377, 1988.","DOI":"10.1007\/BF03349058"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takamatsu K, Nishiyama T, Nakauchi Y, Yamano T, Ohno F. A case of insulin dependent diabetes mellitus associated with relapsing polychondritis, Hashimoto's thyroiditis and pituitary adrenocortical insufficiency in succession. Jpn J Med 28: 232-236, 1989.","DOI":"10.2169\/internalmedicine1962.28.232"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sakane N, Yoshida T, Yoshioka K, Umekawa T, Kondo M. Severe hypoglycemia and type I diabetes with isolated ACTH deficiency. Diabetes Care 18: 1621-1622, 1995.","DOI":"10.2337\/diacare.18.12.1621"},{"key":"10","unstructured":"10. Oishi H, Souda Y, Ito T, Morita H, Oki Y, Nakamura H. A case of insulin-dependent diabetes mellitus with ACTH deficiency contributing frequent hypoglycemia. Tonyobyo To Taisha (Diabetes J) 27: 59-63, 1999 (in Japanese)."},{"key":"11","unstructured":"11. Muro S, Tanaka T, Hanaoka I, Oki S. Ten cases of isolated adrenocorticotropic hormone deficiency. Horumon To Rinsho (Clinical Endocrinology) 49 (Suppl): 57-65, 2001 (in Japanese)."},{"key":"12","unstructured":"12. Kita Y, Matsushita Y, Kato K, et al. Fulminant type 1 diabetes and isolated adrenocorticotropic hormone deficiency in a patient with autoimmune polyglandular endocrine syndrome. Nihon Naibunpitsu Gakkai Zasshi (Folia Endocrinologica Japonica) 87 (Suppl): 32-34, 2011 (in Japanese)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 3: 39-40, 2012.","DOI":"10.1111\/j.2040-1124.2012.00207.x"},{"key":"14","unstructured":"14. Weiner WJ. A differential diagnosis of Parkinsonism. Rev Neurol Dis 2: 124-131, 2005."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lasheen I, Doi SA, Al-Shoumer KA. Glucocorticoid replacement in panhypopituitarism complicated by myelinolysis. Med Princ Pract 14: 115-117, 2005.","DOI":"10.1159\/000083923"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Okada K, Nomura M, Furusyo N, Otaguro S, Nabeshima S, Hayashi J. Amelioration of extrapontine myelinolysis and reversible parkinsonism in a patient with asymptomatic hypopituitarism. Intern Med 44: 739-742, 2005.","DOI":"10.2169\/internalmedicine.44.739"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sajith J, Ditchfield A, Katifi HA. Extrapontine myelinolysis presenting as acute parkinsonism. BMC Neurol 6: 33, 2006.","DOI":"10.1186\/1471-2377-6-33"},{"key":"18","unstructured":"18. Srimanee D, Bhidayasiri R, Phanthumchinda K. Extrapontine myelinolysis in preoperative sellar region tumor: report of two cases. J Med Assoc Thai 92: 1548-1553, 2009."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gujjar A, Al-Mamari A, Jacob PC, Jain R, Balkhair A, Al-Asmi A. Extrapontine myelinolysis as presenting manifestation of adrenal failure: a case report. J Neurol Sci 290: 169-171, 2010.","DOI":"10.1016\/j.jns.2009.11.012"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Imam YZ, Saqqur M, Alhail H, Deleu D. Extrapontine myelinolysis-induced parkinsonism in a patient with adrenal crisis. Case Rep Neurol Med 2012: 327058, 2012.","DOI":"10.1155\/2012\/327058"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wali GM. Parkinsonism associated with Addison's disease. Mov Disord 18: 340-342, 2003.","DOI":"10.1002\/mds.10340"},{"key":"22","unstructured":"22. Stern RA, Prange AJ. Neuropsychiatric aspects of endocrine disorder. In: Comprehensive Textbook of Psychiatry. Kaplan HI, Sadack BJ, Eds. Milliams and Wilkins, Baltimore, 1995: 241-251."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ros-Bernal F, Hunot S, Herrero MT, et al. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A 108: 6632-6637, 2011.","DOI":"10.1073\/pnas.1017820108"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes. Diabetes 54 (Suppl 2): S52-S61, 2005.","DOI":"10.2337\/diabetes.54.suppl_2.S52"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ali F, Rowley M, Jayakrishnan B, Teuber S, Gershwin ME, Mackay IR. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. J Autoimmun 37: 79-87, 2011.","DOI":"10.1016\/j.jaut.2011.05.005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Alexopoulos H, Dalakas MC. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Rev Clin Immunol 9: 1043-1053, 2013.","DOI":"10.1586\/1744666X.2013.845527"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Imagawa A, Hanafusa T, Awata T, et al. Report of the committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: New diagnostic criteria for fulminant type 1 diabetes mellitus (2012). J Diabetes Investig 3: 536-539, 2012.","DOI":"10.1111\/jdi.12024"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kawasaki E, Maruyama T, Imagawa A, et al. Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus. J Diabetes Investig 5: 115-118, 2014.","DOI":"10.1111\/jdi.12119"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gumbiner B, Polonsky KS, Beltz WF, et al. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 70: 1594-1602, 1990.","DOI":"10.1210\/jcem-70-6-1594"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Cutolo M. Autoimmune polyendocrine syndromes. Autoimmun Rev 13: 85-89, 2014.","DOI":"10.1016\/j.autrev.2013.07.006"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hashimoto K, Maruyama H, Nishiyama M, et al. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population. Horm Res 64: 253-260, 2005.","DOI":"10.1159\/000089293"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Arvat E, di Vito L, Maccagno B, et al. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides 18: 885-891, 1997.","DOI":"10.1016\/S0196-9781(97)00016-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kimura T, Shimatsu A, Arimura H, et al. Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2. Endocr J 57: 639-644, 2010.","DOI":"10.1507\/endocrj.K10E-017"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. de Sá LB, Nascif SO, Correa-Silva SR, et al. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus. Metabolism 59: 1536-1542, 2010.","DOI":"10.1016\/j.metabol.2010.01.021"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/20\/54_54.5022\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T15:22:05Z","timestamp":1567264925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/20\/54_54.5022\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":34,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.5022","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}